Type II oestrogen binding site is associated with the major 4S oestrogen receptor isoform in breast tumours.
Using high resolution isoelectric focusing we have been able to identify a low affinity/high capacity oestrogen binding protein, which exhibits an apparent pI of 7.0. Using this system it can be separated from the previously described high affinity oestrogen receptor (ER) isoforms which focus at pI 6.1, 6.3, 6.6 and 6.8. The pI 7.0 protein was detected in 30/30 breast tumours analysed and had the binding characteristics of the cytoplasmic Type II ER (Kd = 88 +/- 8 nM). The concentration of this protein was shown to be significantly correlated with the concentration of the pI 6.6 species, which represents the major 4S isoform. It is not related to any other isoform of ER, and is expressed independently of the progesterone receptor. The importance of this observed relationship with respect to ER function remains obscure, but it may provide new insights into the role of the Type II oestrogen binding site in breast cancer.
Marsigliante
S
S
Dipartimento Biologia, Università di Lecce, Italy.
Biscozzo
L
L
Barker
S
S
Leo
G
G
Puddefoot
J R
JR
Vinson
G P
GP
Storelli
C
C
D001665:Binding Sites; D001943:Breast Neoplasms / Q000378:metabolism*; D017886:Durapatite; D004967:Estrogens / Q000378:metabolism*; D006801:Humans; D006882:Hydroxyapatites; D007525:Isoelectric Focusing; D011960:Receptors, Estrogen / Q000737:chemistry / Q000378:metabolism*
D004967:Estrogens; D006882:Hydroxyapatites; D011960:Receptors, Estrogen; D017886:Durapatite